Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any exudative vitreoretinopathy in which the cause of the disease is a mutation in the ZNF408 gene.
Features include always present findings: Exudative vitreoretinopathy; and common findings: Retinal detachment, Esodeviation, Horizontal nystagmus, and Myopia and others. 17 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 10 | Retinal detachment, Tractional retinal detachment, Falciform retinal fold |
ZNF408 function has not been fully characterized.
Exudative vitreoretinopathy 6 is associated with mutations in the ZNF408 gene on chromosome 11.
Genetic testing for ZNF408 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for exudative vitreoretinopathy 6 has been reported in the published literature.
Phenotype severity distribution: 1 always present feature, 5 common features.
No clinical trials have been registered for exudative vitreoretinopathy 6.
50 publications have been identified in PubMed for exudative vitreoretinopathy 6. Research spans Case Report / Case Series (30%), Basic Science / Preclinical (26%), and Clinical Trial Publication (16%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 15 | 30% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 6:54 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Muscles
2 |
Patchy atrophy of the retinal pigment epithelium, Chorioretinal atrophy |
Laboratory research
13 |
26% |
Clinical study results | 8 | 16% |
Disease patterns and progression | 7 | 14% |
Research summaries | 4 | 8% |
Testing and diagnosis research | 2 | 4% |
New treatment approaches | 1 | 2% |
Li J (2026). [PMID: 42007156](https://pubmed.ncbi.nlm.nih.gov/42007156/). *Am J Transl Res*. [Basic Science / Preclinical]
Luvisi JR (2026). [PMID: 40334027](https://pubmed.ncbi.nlm.nih.gov/40334027/). *Unknown Journal*. [Review / Meta-Analysis]
Anne RP (2026). [PMID: 42231307](https://pubmed.ncbi.nlm.nih.gov/42231307/). *BMC Pediatr*. [Review / Meta-Analysis]
Petchyim S (2026). [PMID: 41996523](https://pubmed.ncbi.nlm.nih.gov/41996523/). *J Pediatr Ophthalmol Strabismus*. [Clinical Trial Publication]
Kanai A (2026). [PMID: 42018116](https://pubmed.ncbi.nlm.nih.gov/42018116/). *Jpn J Ophthalmol*. [Case Report / Case Series]
Chokchaitanasin R (2026). [PMID: 41022191](https://pubmed.ncbi.nlm.nih.gov/41022191/). *American journal of ophthalmology*. [Basic Science / Preclinical]
Xue L (2026). [PMID: 42155446](https://pubmed.ncbi.nlm.nih.gov/42155446/). *Structure*. [Basic Science / Preclinical]
Grassi P (2026). [PMID: 41994251](https://pubmed.ncbi.nlm.nih.gov/41994251/). *Saudi J Ophthalmol*. [Clinical Trial Publication]
Watanabe W (2026). [PMID: 41957171](https://pubmed.ncbi.nlm.nih.gov/41957171/). *Sci Rep*. [Diagnostic / Biomarker]
Okamoto M (2025). [PMID: 39197492](https://pubmed.ncbi.nlm.nih.gov/39197492/). *Ophthalmology. Retina*. [Case Report / Case Series]